One of the most convenient and versatile features in Microsoft Edge is Read aloud. Listen as Microsoft Edge reads webpage content to you using AI-powered technology to parse the text. Whether ...

Pfizer’s decision to cut its early-stage cancer asset was due to “strategic business reasons” and not driven by safety or efficacy concerns. Pfizer has pulled the plug on an early-stage PD-L1 program ...

The Houston Police Department is facing pressure to fire one of its officers after a viral social media video of her using racist slurs surfaced this week. In the video posted to Instagram, a woman, ...

Pfizer has abandoned work on a PD-L1-targeting drug that was being tested in patients with various cancers. The phase 1 study had been evaluating PF‑08046037—an immunostimulatory drug conjugate (ISAC) ...

-- problem determination log messages that were logged in the notification log. -- attention: autre date que NULL semble pas marcher dans la fonction -- Information returned by the ...

More than a year after licensing its PD-1xVEGF bispecific, Merck & Co. has finally unveiled the first clinical data from the antibody, which suggests the drug boasts similar safety and efficacy in non ...

The Merck update, which will shed light on a $588 million bet to succeed Keytruda, is part of a roster of presentations that could shape the future of ADCs, protein degraders and KRAS-targeted ...